Comparison of the Efficacies of Loop-Mediated Isothermal Amplification, Fluorescence Smear Microscopy and Culture for the Diagnosis of Tuberculosis by George, Geojith et al.
Comparison of the Efficacies of Loop-Mediated
Isothermal Amplification, Fluorescence Smear
Microscopy and Culture for the Diagnosis of Tuberculosis
Geojith George
1, Prem Mony
2, John Kenneth
1*
1Division of Infectious Disease, St. John’s Research Institute, Bangalore, India, 2Division of Epidemiology and Biostatistics, St. John’s Research Institute, Bangalore, India
Abstract
Background: Despite the advent of novel diagnostic techniques, smear microscopy remains as the most practical test
available in resource-limited settings for tuberculosis (TB) diagnosis. Due to the low sensitivity of microscopy and the long
time required for culture, feasible and accessible rapid diagnostic methods are urgently needed. Loop-mediated Isothermal
Amplification (LAMP) is a promising nucleic-acid amplification assay, which could be accessible, cost-effective and more
suited for use with unpurified samples.
Methodology/Principal Findings: In the current study, the objective was to assess the efficacy of a LAMP assay for
tuberculosis compared with fluorescence smear microscopy as well as Lo ¨wenstein-Jensen (LJ) and Mycobacteria Growth
Indicator Tube (MGIT) cultures for the diagnosis of pulmonary tuberculosis using sputum samples. Smear microscopy and
culture were performed for decontaminated and concentrated sputum from TB suspects and the LAMP was also performed
on these specimens. The LAMP and smear microscopy were compared, in series and in parallel, to culture. LAMP and smear
microscopy showed sensitivities of 79.5% and 82.1% respectively and specificities of 93.8% and 96.9% respectively,
compared to culture. LAMP and smear in series had sensitivity and specificity of 79.5% and 100.0% respectively. LAMP and
smear in parallel had sensitivity and specificity of 82.1% and 90.6% respectively.
Conclusions/Significance: The overall efficacies of LAMP and fluorescence smear microscopy in the current study were high
and broadly similar. LAMP and smear in series had high specificity (100.0%) and can be used as a rule-in test combination.
However, the performance of LAMP in smear negative samples was found to be insufficient.
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Introduction
Tuberculosis (TB) is one of the oldest diseases that still afflict
mankind. The dual specters of TB and AIDS have drawn recent
attention to the lack of a suitable diagnostics for TB [1,2,3,4]. TB
case detection is the first hurdle towards tackling the TB epidemic
[5]. However, the culture which is considered as the ‘gold stan-
dard’ of TB diagnosis takes 3–6 weeks, leaving the less sensitive
smear microscopy as the only feasible rapid test presently. Even
the automated liquid culture systems like BACTEC or Mycobac-
teria Growth Indicator Tube (MGIT) take 1–6 weeks for growth
detection. The utility of microscopy decreases radically in pauci-
bacillary and HIV positive TB suspects. Smear negative carriers,
even if considered less infectious, can still spread TB [6]. The long
delays in diagnosis result in patients dropping out or continuing to
spread TB till they are correctly diagnosed, found and treated
[7,8]. While treating all suspected cases adds significantly to the cost
of TB control programs, it also exposes subjects to unnecessary
drugs and worsens the emergence of drug resistance. A highly
sensitive rule-in test can significantly improve the case detection
whereas a highly specific rule-out test can reduce the turnaround
time and the duration of respiratory isolation as well as avoid
unnecessary administration of potentially toxic drugs [9,10,11].
Despite the recent advances in TB diagnosis [12], cost and
accessibility continue to be the major limiting factors in the effort
to eradicate tuberculosis [13]. Notwithstanding the advent of novel
diagnostic techniques, smear microscopy remains the most prac-
tical test available in resource-limited settings, where majority of
the TB is present. Considerable effort and resources have been
invested in developing novel diagnostics and improving existing
ones [5,14,15]. However, the improvements in sensitivity and
specificity achieved thus far have not been extensively demon-
strated or rigorously evaluated with actual patient samples in field
conditions. Nucleic-acid amplification based tests (NAATs) are
of particular interest, since they may be eminently suited for use
with respiratory specimens [16] and due to their rapidity and
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Nucleic acid assays are also more amenable to miniaturization and
microfabrication, opening new vistas for cost reduction and auto-
mation [20]. Loop-mediated Isothermal Amplification (LAMP) was
shown to be a promising nucleic-acid amplification assay, which
could be accessible and cost-effective [21]. It could also be more
robust than other nucleic acid amplification tests, retaining the
specificity across wider pH and temperature gradients and showing
lesser inhibition in unpurified samples [22]. Suitability of LAMP as
a point of care test for the diagnosis of pulmonary tuberculosis is
beginning to be evaluated with clinical samples [23,24].
The LAMP assay was found to be suitable for the laboratory
identification of M. tuberculosis (MTB) in culture isolates by the
authors previously [25]. In the current study, the objective was to
assess the efficacy of a LAMP assay for tuberculosis, alone and
in combination with fluorescence smear microscopy as well as
Lo ¨wenstein-Jensen (LJ) and Mycobacteria Growth Indicator Tube
(MGIT) cultures for the detection of M. tuberculosis from archived
sputum samples.
Materials and Methods
Ethics Statement
This study was reviewed and cleared by the St. John’s Medical
College Hospital ethics review board. Written informed consent
was obtained from all the participants. The data were analyzed
anonymously.
Participants
To compare ‘LAMP’ with the fluorescence smear microscopy
and LJ culture, we used 78 sputum samples obtained from as many
TB suspects from the Palamaner region in the state of Andhra
Pradesh in southern India.
Procedures
Samples were collected over a period of six months starting
from January 2007. These were decontaminated using NALC-
NaOH method and stored at 220uC. Sputum sample digestion-
decontamination, LJ culture [26] and auramine O fluorescence
microscopy were performed as per standard literature [27]. MGIT
cultures were performed as per the manufacturer’s instructions.
Decontaminated sputum was processed (January to February
2010) using the ‘AMPLICOR Respiratory Specimen Preparation
Kit’ (Roche Diagnostics GmbH, Mannheim), according to manu-
facturer’s instructions and the resulting lysate was stored at 220uC.
LJ and MGIT cultures were used as the ‘gold standard’ against
which other tests could be assessed. The tests were executed and
read by experienced personnel, who were blinded to the results of
the other tests.
LAMP reaction
The M. tuberculosis specific LAMP reaction was carried out as
published previously [28], but was modified to suit local conditions
[25]. Briefly, the primers, along with 5 ml of the sample lysate were
heat denatured for 3 minutes and then annealed prior to adding
the enzyme-dNTP mix. The LAMP reaction was carried out in a
final volume of 25 ml in a 120 minute format and was terminated
by heating at 80uC for 2 minutes. This assay is specific for the
rimM sequence of M. tuberculosis and M. bovis. DNA extracted from
M. tuberculosis ATCC strain H37Rv was used as the positive control
and PCR grade water as the negative control. The Bst polymerase
(Large fragment) was purchased from New England Biolabs Inc.
The primers and SYBR Green I were acquired from Sigma-
Aldrich Corporation, India. The final reaction volume was 25 ml
(including sample volume 5 ml).The results were visualized by
adding 2 ml of 10-fold diluted original SYBR Green I after
amplification, and confirmed by agarose gel electrophoresis [29].
Statistical methods
Data was analyzed using SPSS software - version 17 ( IBM
corporation 2010). Sensitivity, specificity [30] as well as positive
and negative predictive values (PPV & NPV) [31] were calculated
for the LAMP and smear microscopy in comparison with culture
as the gold standard. LAMP and smear microscopy testing in
series and parallel were also compared against the culture [32].
For this purpose, LAMP and smear microscopy were compared in
series (LAMP performed only if smear positive and considered TB
positive if both tests are positive or TB negative if either test is
negative) and in parallel (LAMP performed for all samples and
considered TB positive if either smear or LAMP is positive and TB
negative if both are negative). Serial testing improves the specificity
but lowers the sensitivity. It also reduces the cost of the second test
as it is performed for only those samples positive by the first test.
Parallel testing improves the sensitivity, while decreasing the
specificity. Cohen’s kappa was calculated as a measure of agree-
ment between the tests [33].
Results and Discussion
The results of the study are outlined in table 1. Samples were
considered to be culture negative if no growth was detected in both
LJ and MGIT cultures. Samples were considered to be ‘culture
positive’ if growth was detected in either LJ or MGIT cultures. Of
the 78 samples tested, 7 showed contamination for both LJ and
MGIT cultures and were omitted from analysis. 34 samples were
LAMP positive, of which one was detected to be contaminated on
both LJ and MGIT cultures. Of the 44 LAMP negative samples, 6
were detected to be contaminated on both LJ and MGIT cultures.
33 samples were smear positive. Of the 45 smear negative samples,
7 were detected to be contaminated on both LJ and MGIT cul-
tures. Non-contaminated culture results were available for 33
positive and 38 negative samples each for the LAMP and smear.
The performance of LAMP and smear as compared to the LJ or
MGIT culture is given in table 2. Efficacy of the LAMP and smear
microscopy in series and in parallel is depicted in table 3.
LAMP detects the presence/absence of the genetic material of
M. tuberculosis. Smear microscopy detects the morphology and
culture methods differentiate based on the physiology of the viable
organism. These different approaches could be complementary. In
this study, the LAMP was observed to have high sensitivity and
specificity for samples with concordant culture and smear results.
The overall efficacy of LAMP and fluorescence smear microscopy
in the current study was high and broadly similar. However, the
performance of LAMP in smear negative samples was found to be
suboptimal.
The LAMP showed excellent sensitivity (96.7%) and specificity
(100.0%) for those samples with analogous culture and smear
results (n=59), as shown in table 2. These values are similar to
those reported earlier [24]. LAMP showed poor sensitivity (22.2%)
and specificity (33.3%) for the samples with discordant culture and
smear results (n=12, Table 2). The overall sensitivity (79.5%) and
specificity (93.8%) of LAMP was slightly lower than that of the
smear microscopy (82.1% and 96.9% respectively) for the entire
samples (n=71) when compared to culture. LAMP showed a
sensitivity and specificity of 96.9% and 100.0% respectively for
smear positive samples (n=33). The specificity of LAMP for smear
negative samples (n=38) was 93.6%. The sensitivity of LAMP for
smear negatives could not be calculated due to the limited number
of samples. When both the LAMP and smear microscopy were
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were 79.5% and 100.0% respectively (n=71). When both the
LAMP and smear microscopy were performed in parallel (n=71),
the sensitivity and specificity observed were 82.1% and 90.6%
respectively (Table 3). Commercial NAATs had shown pooled
sensitivity and specificity of 96.0% and 85.0% respectively among
smear positive samples and 66.0% and 98.0% respectively among
smear negative samples[34]. In-house PCR assays were reported
to show pooled sensitivity and specificity of 96.0% and 81.0%
respectively for smear positive samples [35], indicating that a
standardized LAMP can perform potentially better than or
equivalent to PCR-based methods.
LAMP does not appear to pick up any additional true positives
or pick up any that the smear missed, in smear negative samples.
Hence the LAMP assay in the current format may be useful only
in diagnosis of smear positive samples or as a rule-in test for smear
negative samples (specificity of 93.6%). The utility of LAMP as a
tool to resolve differences between the culture and smear results is
questionable, especially when smear negative samples are
involved. However, this has to be validated with larger sample sets.
Discordant results between the LAMP and smear or culture can
arise if non-tuberculous Mycobacteria (NTM) are present [36,37]
or if cultures are contaminated [38]. NTM have been reported at
high frequencies from southern India [39,40]. The development of
a LAMP assay capable of identifying both MTBC and NTM can
improve the sensitivity and specificity significantly. In this study,
the one sample that was LAMP negative but smear and LJ positive
was later identified as MTB by the ‘GenoType MTBC’ assay
(HAIN lifesciences GmbH, Germany) as well as by LAMP for
culture lysates. These rule out NTM or sequence variation as
reasons for amplification failure with this sample and indicate the
lower concentration of nucleic acid present or the presence of
Table 1. Results of LAMP, smear and culture.
LAMP Smear Number of cultured samples LJ or MGIT culture Number of total samples
Either + Both - Both Contaminated
+ + 31 31 0 0 31
+ 2 20 2 1 3
2 + 21 1 0 2
2 2 36 7 29 6 42
Total 71 39 32 7 78
*Positive results marked as ‘+’ and Negative results as ‘2‘.
doi:10.1371/journal.pone.0021007.t001
Table 2. Three-way comparison of LAMP, smear and culture.
Culture + Culture 2 Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Positive
likelihood ratio
Negative
likelihood ratio k-value
LAMP + 31 2 79.5 93.8 93.9 79.0 12.7 0.2 0.7
LAMP 2 83 0
n=71 95% CI= 64.5–89.2 79.9–98.3 80.4–98.3 63.7–88.9 3.3–49.1 0.1–0.4 0.6–0.9
Culture + Culture 2
Smear + 32 1 82.1 96.9 97.0 81.6 26.3 0.2 0.8
Smear 2 73 1
n=71 95% CI= 67.3–91.0 84.3–99.5 84.7–99.5 66.6–90.8 3.8–181.7 0.1–0.4 0.6–0.9
Smear + Smear 2
LAMP + 31 2 93.9 94.7 93.9 94.7 17.9 0.1 0.9
LAMP 2 23 6
n=71 95% CI= 80.4–98.3 82.7–98.5 80.4–98.3 82.7–98.5 4.6–69.0 0.0–0.2 0.8–1.0
Culture +
Smear +
Culture 2
Smear 2
LAMP + 29 0 96.7 100.0 100.0 96.7 NA 0.0 1.0
LAMP 2 12 9
n=59 95% CI= 83.3–99.4 88.3–100.0 88.3–100.0 83.3–99.4 NA 0.0–0.2 0.9–1.0
Culture +
Smear 2
Culture 2
Smear +
LAMP + 2 2 22.2 33.3 50.0 12.5 0.3 2.3 NA
LAMP - 71
n=12 95% CI= 6.3–54.7 6.2–79.2 15.0–85.0 2.2–47.1 0.1–1.4 0.5–12.0 NA
doi:10.1371/journal.pone.0021007.t002
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tuberculosis DNA and re-amplified. As all these samples amplified,
presence of inhibitors can be ruled out.
The high sensitivity observed for smear microscopy in this study
may be due to the nature of sampling, better lab practices or the
high prevalence of TB as observed elsewhere [41,42]. One of the
factors reducing the sensitivity of the LAMP may be the lysis of
specimens upon storage [43]. Subsequent supernatant removal
and NaOH treatment of lysed specimens may reduce the amount
of amplifiable DNA available. Washing and NaOH-free methods
for sputum processing will be of considerable value to NAATs.
Conclusions
LAMP appears to be suitable for smear positive specimens with
concordant culture results, but was ineffective in smear negative
samples. LAMP and smear in series had high specificity (100.0%)
and can be used as a rule-in test combination. An improved
LAMP alone or together with smear microscopy can offer same-
day diagnosis and has the potential to reduce the drop-out rate
substantially. However, these findings need to be substantiated
further with larger sample sizes and in different geographical
settings. Inter-reader reproducibility and the performance with
smear negative samples also need further evaluation. Suitably
modified, LAMP can potentially improve the diagnosis of TB in
resource limited settings.
Limitations
In the current study, sample size under certain subtypes was too
limited to arrive at statistically significant estimates of efficacy. The
sampling was not continuous due to limited availability of stored
samples. Speciation of all the cultured samples were not performed
and as such it is not possible to determine how many of the culture
or smear positives were NTM, which the LAMP will not detect
using current set of primers. The HIV status was not ascertained
for the study samples. However, it is unlikely that HIV had a
significant impact on the findings, as other studies in the same
region indicate ,1% prevalence for HIV.
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